- Home
- ELPC vs CRL Comparison
ELPC vs CRL Comparison
Compare ELPC & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELPC
- CRL
- Stock Information
- Founded
- ELPC 1954
- CRL 1947
- Country
- ELPC Brazil
- CRL United States
- Employees
- ELPC N/A
- CRL N/A
- Industry
- ELPC Electric Utilities: Central
- CRL Biotechnology: Commercial Physical & Biological Resarch
- Sector
- ELPC Utilities
- CRL Health Care
- Exchange
- ELPC Nasdaq
- CRL Nasdaq
- Market Cap
- ELPC 6.1B
- CRL 7.1B
- IPO Year
- ELPC N/A
- CRL 2000
- Fundamental
- Price
- ELPC $7.70
- CRL $158.20
- Analyst Decision
- ELPC
- CRL Buy
- Analyst Count
- ELPC 0
- CRL 14
- Target Price
- ELPC N/A
- CRL $184.85
- AVG Volume (30 Days)
- ELPC 4.1K
- CRL 804.7K
- Earning Date
- ELPC 01-01-0001
- CRL 08-06-2025
- Dividend Yield
- ELPC 5.38%
- CRL N/A
- EPS Growth
- ELPC 31.95
- CRL N/A
- EPS
- ELPC 0.17
- CRL N/A
- Revenue
- ELPC $4,033,509,015.00
- CRL $4,022,597,000.00
- Revenue This Year
- ELPC N/A
- CRL N/A
- Revenue Next Year
- ELPC $5.55
- CRL $2.49
- P/E Ratio
- ELPC $11.99
- CRL N/A
- Revenue Growth
- ELPC 6.92
- CRL N/A
- 52 Week Low
- ELPC $5.04
- CRL $91.86
- 52 Week High
- ELPC $8.87
- CRL $254.15
- Technical
- Relative Strength Index (RSI)
- ELPC 38.59
- CRL 57.66
- Support Level
- ELPC $8.23
- CRL $152.73
- Resistance Level
- ELPC $8.47
- CRL $168.12
- Average True Range (ATR)
- ELPC 0.17
- CRL 5.02
- MACD
- ELPC -0.09
- CRL 0.13
- Stochastic Oscillator
- ELPC 29.23
- CRL 47.51
About ELPC Companhia Paranaense de Energia (COPEL) (each representing four (4))
Cia Paranaense De Energia Copel is engaged in the areas of generation, transmission, commercialization and distribution of energy. It operates a comprehensive and effective electrical system with its own generating plants, transmission lines, substations, electrical lines and grids of the distribution system. The company's reportable segments include Power generation and transmission, Power distribution, GAS, Power sale, Services, and Holding. The majority of its revenue is generated from the Power generation and transmission segment under which it produces electricity from hydraulic, wind, and thermal projects and provides services of transmission and transformation of electric power and other related services.
About CRL Charles River Laboratories International Inc.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.